ANI Pharma (ANIP) Tops Q4 EPS by 1c, Miss on Revenues; Offers FY18 EPS Guidance Above Consensus
Go back to ANI Pharma (ANIP) Tops Q4 EPS by 1c, Miss on Revenues; Offers FY18 EPS Guidance Above Consensus| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 76.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.14 | 52 Week High | $70.92 | |||
| Open | $76.14 | 52 Week Low | $26.80 | |||
| Day High | $76.14 | P/E | N/A | |||
| Day Low | $76.14 | EPS | $-0.96 | |||
| Volume | 321 | |||||
